IBDEI0LJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9798,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9798,1,2,0)
 ;;=2^J7610
 ;;^UTILITY(U,$J,358.3,9798,1,3,0)
 ;;=3^ALBUTEROL,INHALE,COMPD,CONCENTRATE FRM 1MG
 ;;^UTILITY(U,$J,358.3,9799,0)
 ;;=J7613^^66^639^5^^^^1
 ;;^UTILITY(U,$J,358.3,9799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9799,1,2,0)
 ;;=2^J7613
 ;;^UTILITY(U,$J,358.3,9799,1,3,0)
 ;;=3^ALBUTEROL,INHALE,NON-COMPD,UNIT DOSE 1MG
 ;;^UTILITY(U,$J,358.3,9800,0)
 ;;=J7611^^66^639^4^^^^1
 ;;^UTILITY(U,$J,358.3,9800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9800,1,2,0)
 ;;=2^J7611
 ;;^UTILITY(U,$J,358.3,9800,1,3,0)
 ;;=3^ALBUTEROL,INHALE,NON-COMPD,CONCENTRATE FRM 1MG
 ;;^UTILITY(U,$J,358.3,9801,0)
 ;;=J7644^^66^639^15^^^^1
 ;;^UTILITY(U,$J,358.3,9801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9801,1,2,0)
 ;;=2^J7644
 ;;^UTILITY(U,$J,358.3,9801,1,3,0)
 ;;=3^IPRATROPIUM BROMIDE INHALE,NON-COMPD,UNIT PER MG
 ;;^UTILITY(U,$J,358.3,9802,0)
 ;;=30906^^66^639^8^^^^1
 ;;^UTILITY(U,$J,358.3,9802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9802,1,2,0)
 ;;=2^30906
 ;;^UTILITY(U,$J,358.3,9802,1,3,0)
 ;;=3^CONTROL NOSEBLEED,POST W/ PACKS/CAUTERY;SUBSQ
 ;;^UTILITY(U,$J,358.3,9803,0)
 ;;=94010^^66^639^16^^^^1
 ;;^UTILITY(U,$J,358.3,9803,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9803,1,2,0)
 ;;=2^94010
 ;;^UTILITY(U,$J,358.3,9803,1,3,0)
 ;;=3^Peak Flow Spirometry
 ;;^UTILITY(U,$J,358.3,9804,0)
 ;;=94760^^66^639^17^^^^1
 ;;^UTILITY(U,$J,358.3,9804,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9804,1,2,0)
 ;;=2^94760
 ;;^UTILITY(U,$J,358.3,9804,1,3,0)
 ;;=3^Pulse Oximetry
 ;;^UTILITY(U,$J,358.3,9805,0)
 ;;=33010^^66^640^14^^^^1
 ;;^UTILITY(U,$J,358.3,9805,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9805,1,2,0)
 ;;=2^33010
 ;;^UTILITY(U,$J,358.3,9805,1,3,0)
 ;;=3^PERICARDIOCENTESIS,INIT
 ;;^UTILITY(U,$J,358.3,9806,0)
 ;;=33210^^66^640^13^^^^1
 ;;^UTILITY(U,$J,358.3,9806,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9806,1,2,0)
 ;;=2^33210
 ;;^UTILITY(U,$J,358.3,9806,1,3,0)
 ;;=3^PACING,TRANSVENOUS(TEMP)
 ;;^UTILITY(U,$J,358.3,9807,0)
 ;;=36000^^66^640^11^^^^1
 ;;^UTILITY(U,$J,358.3,9807,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9807,1,2,0)
 ;;=2^36000
 ;;^UTILITY(U,$J,358.3,9807,1,3,0)
 ;;=3^IV INSERTION,VEIN
 ;;^UTILITY(U,$J,358.3,9808,0)
 ;;=36011^^66^640^10^^^^1
 ;;^UTILITY(U,$J,358.3,9808,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9808,1,2,0)
 ;;=2^36011
 ;;^UTILITY(U,$J,358.3,9808,1,3,0)
 ;;=3^IV INSERTION,JUGULAR OR FEMORAL
 ;;^UTILITY(U,$J,358.3,9809,0)
 ;;=36556^^66^640^3^^^^1
 ;;^UTILITY(U,$J,358.3,9809,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9809,1,2,0)
 ;;=2^36556
 ;;^UTILITY(U,$J,358.3,9809,1,3,0)
 ;;=3^CENTRAL VENOUS LINE
 ;;^UTILITY(U,$J,358.3,9810,0)
 ;;=36600^^66^640^2^^^^1
 ;;^UTILITY(U,$J,358.3,9810,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9810,1,2,0)
 ;;=2^36600
 ;;^UTILITY(U,$J,358.3,9810,1,3,0)
 ;;=3^ARTERIAL PUNCTURE (ABG)
 ;;^UTILITY(U,$J,358.3,9811,0)
 ;;=36620^^66^640^1^^^^1
 ;;^UTILITY(U,$J,358.3,9811,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9811,1,2,0)
 ;;=2^36620
 ;;^UTILITY(U,$J,358.3,9811,1,3,0)
 ;;=3^ARTERIAL CATHETER PERCUTANEOUS
 ;;^UTILITY(U,$J,358.3,9812,0)
 ;;=36680^^66^640^9^^^^1
 ;;^UTILITY(U,$J,358.3,9812,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9812,1,2,0)
 ;;=2^36680
 ;;^UTILITY(U,$J,358.3,9812,1,3,0)
 ;;=3^INEROSSEOUS NEEDLE PLACEMENT
 ;;^UTILITY(U,$J,358.3,9813,0)
 ;;=37195^^66^640^18^^^^1
 ;;^UTILITY(U,$J,358.3,9813,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,9813,1,2,0)
 ;;=2^37195
 ;;^UTILITY(U,$J,358.3,9813,1,3,0)
 ;;=3^THROMBOLYSIS CEREBRAL BY IV INFUSION
